I am a Nanomedicine Research Associate working within the Nanomedicine Research Group, based at the Department of Chemistry. Led by Prof. Steve Rannard, the group is investigating novel material approaches to overcoming current limitations in poorly water soluble drug therapies, particularly focused on Antiretroviral Therapies. I have a multidiscipline background, having worked in the areas of Materials Chemistry, Pharmacology, Immunology, and Biological Containment Level 3.
As a Research Associate I have previously worked on a project funded by the Clinton Health Access Initiative (CHAI). The Clinton Health Access Initiative, Inc. (CHAI) was founded in 2002 with a transformational goal: help save the lives of millions of people living with HIV/AIDS in the developing world by dramatically scaling up antiretroviral treatment. That project aimed to develop novel formulations of existing antiretroviral drugs, co-formulated with agents to boost the effectiveness of the the original therapeutic compound. I am now engaged in a large collaborative project between the Department of Chemistry and Department of Pharmacology, based at University of Liverpool, and The Division of Clinical Pharmacology, at Johns Hopkins University, Baltimore USA. The project aims to develop novel long acting injectable (LAI) formulations of antiretroviral drug therapies.